Patients with malignant tumors have a high risk and poor prognosis of venous thromboembolism (VTE) . Choosing targeted VTE risk assessment tools and using them correctly can predict and stratify the risk of VTE in cancer patients, and then guide medical and nursing staff to adopt appropriate preventive measures to reduce the incidence of VTE. This article reviewed the risk assessment tools for malignant tumor-associated VTE so as to provide a reference for clinical risk assessm...
